国际呼吸杂志
國際呼吸雜誌
국제호흡잡지
INTERNATIONAL JOURNAL OF RESPIRATION
2014年
15期
1155-1159
,共5页
姬晓青%亓卫东%李新玲%鲁德玕
姬曉青%亓衛東%李新玲%魯德玕
희효청%기위동%리신령%로덕간
慢性阻塞性肺疾病%细菌%病原学%耐药性
慢性阻塞性肺疾病%細菌%病原學%耐藥性
만성조새성폐질병%세균%병원학%내약성
Chronic obstructive pulmonary disease%Bacteria%Etiology%Drug resistance
目的:了解某院慢性阻塞性肺疾病急性加重期(acute exacerbation of chronic obstructive pulmonary disease,AECOPD)患者下呼吸道病原菌分布及药敏情况,指导临床合理应用抗菌药物。方法对该院2007年4月至2011年12月住院的718例 AECOPD 患者痰培养及药敏结果进行回顾性分析。结果共分离出病原菌479株,其中革兰阴性杆菌266株(55.5%),主要为克雷伯菌属、铜绿假单胞菌、大肠埃希菌及不动杆菌属;革兰阳性球菌144株(30.1%),以葡萄球菌属和肺炎链球菌为主;真菌69株(14.4%),以白色假丝酵母菌为主。极重度 COPD 患者革兰阴性杆菌(64.7% vs 59.8% vs 49.1%)和真菌的检出率(20.6% vs 18.5% vs 9.0%)均高于重度和中度患者(革兰阴性杆菌χ2=7.42,P <0.05;真菌χ2=9.95,P <0.05)。革兰阴性杆菌耐药率较低的为亚胺培南、头孢哌酮/舒巴坦、多黏菌素、莫西沙星和阿米卡星;革兰阳性球菌耐药率较低的为万古霉素、替考拉宁、利奈唑胺、喹奴普汀/达福普汀和夫西地酸。结论 AECOPD 患者下呼吸道感染病原菌以革兰阴性杆菌为主,是肺功能差、病情严重的患者的优势致病菌。
目的:瞭解某院慢性阻塞性肺疾病急性加重期(acute exacerbation of chronic obstructive pulmonary disease,AECOPD)患者下呼吸道病原菌分佈及藥敏情況,指導臨床閤理應用抗菌藥物。方法對該院2007年4月至2011年12月住院的718例 AECOPD 患者痰培養及藥敏結果進行迴顧性分析。結果共分離齣病原菌479株,其中革蘭陰性桿菌266株(55.5%),主要為剋雷伯菌屬、銅綠假單胞菌、大腸埃希菌及不動桿菌屬;革蘭暘性毬菌144株(30.1%),以葡萄毬菌屬和肺炎鏈毬菌為主;真菌69株(14.4%),以白色假絲酵母菌為主。極重度 COPD 患者革蘭陰性桿菌(64.7% vs 59.8% vs 49.1%)和真菌的檢齣率(20.6% vs 18.5% vs 9.0%)均高于重度和中度患者(革蘭陰性桿菌χ2=7.42,P <0.05;真菌χ2=9.95,P <0.05)。革蘭陰性桿菌耐藥率較低的為亞胺培南、頭孢哌酮/舒巴坦、多黏菌素、莫西沙星和阿米卡星;革蘭暘性毬菌耐藥率較低的為萬古黴素、替攷拉寧、利奈唑胺、喹奴普汀/達福普汀和伕西地痠。結論 AECOPD 患者下呼吸道感染病原菌以革蘭陰性桿菌為主,是肺功能差、病情嚴重的患者的優勢緻病菌。
목적:료해모원만성조새성폐질병급성가중기(acute exacerbation of chronic obstructive pulmonary disease,AECOPD)환자하호흡도병원균분포급약민정황,지도림상합리응용항균약물。방법대해원2007년4월지2011년12월주원적718례 AECOPD 환자담배양급약민결과진행회고성분석。결과공분리출병원균479주,기중혁란음성간균266주(55.5%),주요위극뢰백균속、동록가단포균、대장애희균급불동간균속;혁란양성구균144주(30.1%),이포도구균속화폐염련구균위주;진균69주(14.4%),이백색가사효모균위주。겁중도 COPD 환자혁란음성간균(64.7% vs 59.8% vs 49.1%)화진균적검출솔(20.6% vs 18.5% vs 9.0%)균고우중도화중도환자(혁란음성간균χ2=7.42,P <0.05;진균χ2=9.95,P <0.05)。혁란음성간균내약솔교저적위아알배남、두포고동/서파탄、다점균소、막서사성화아미잡성;혁란양성구균내약솔교저적위만고매소、체고랍저、리내서알、규노보정/체복보정화부서지산。결론 AECOPD 환자하호흡도감염병원균이혁란음성간균위주,시폐공능차、병정엄중적환자적우세치병균。
Objective To investigate the characteristics of the distribution and drug resistance of bacteria in lower respiratory tract isolated from patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD)and guide clinical rational application of antimicrobial agents.Methods Sputum culture and antimicrobial susceptibility results of 718 patients with AECOPD who were hospitalized in a hospital between April 2007 and December 201 1 were retrospectively analysed.Results A total of 479 strains were isolated from all sputum samples,55.5% of them were Gram-negative bacillus including Klebsiella,Pseudomonas aeruginosa,Escherichia coli and Acinetobacter as the main pathogens. 30.1% were Gram-positive cocci mainly including Staphylococcus and streptococcus pneumoniae.14.4%were fungus athogens and Candida albicans was the most commom pathogens.The relevance ratio of Gram-negative bacillus (64.7% vs 59.8% vs 49.1 %)and fungus (20.6% vs 18.5% vs 9.0%)in very severe patients was higher than in severe or moderate ones (gram negative bacillus:χ2 =7.42,P <0.05. fungal:χ2 =9.95,P <0.05).The results of drug sensitivity test were:most of the Gram-negative bacillis were more sensitive to imipenem,cefoperazone/sulbactam,polymyxin,moxifloxacin and amikacin and most of the Gram-positive bacilli were more sensitive to vancomycin,teicoplanin,linezolid,quinupristin/dalfopristin and fusidic acid.Conclusions The main pathogenics in lower respiratory tract of patients with AECOPD were Gram-negative bacillus,which were the advantage ones of the more severe cases with poor lung function.